226 related articles for article (PubMed ID: 14871579)
1. Subacute toxicity and toxicokinetics of CJ-10882, a type IV phosphodiesterase inhibitor, after 4-week repeated oral administration in dogs.
Han J; Shin HC; Kim JC; Kim B
Food Chem Toxicol; 2004 Mar; 42(3):373-80. PubMed ID: 14871579
[TBL] [Abstract][Full Text] [Related]
2. Subacute toxicities and toxicokinetics of DA-8159, a new phosphodiesterase type V inhibitor, after single and 4-week repeated oral administration in rats.
Shim HJ; Kim YC; Jang JM; Park KJ; Kim DH; Kang KK; Ahn BO; Kwon JW; Kim WB; Lee MG
Biopharm Drug Dispos; 2003 Dec; 24(9):409-18. PubMed ID: 14689469
[TBL] [Abstract][Full Text] [Related]
3. Subacute toxicity and toxicokinetics of a new antibiotic, DW-224a, after single and 4-week repeated oral administration in dogs.
Han J; Kim JC; Chung MK; Kim B; Choi DR
Biol Pharm Bull; 2003 Jun; 26(6):832-9. PubMed ID: 12808295
[TBL] [Abstract][Full Text] [Related]
4. 4-Week repeated intravenous dose toxicity study of a new camptothecin anticancer agent CKD-602 in dogs.
Kim JC; Shin DH; Park SH; Park SC; Kim YB; Kim HC; Cha SW; Cho KH; Kang BH; Chung MK
Food Chem Toxicol; 2005 May; 43(5):699-706. PubMed ID: 15778009
[TBL] [Abstract][Full Text] [Related]
5. Subacute toxicities and toxicokinetics of a new erectogenic, DA-8159, after single and 4-week repeated oral administration in dogs.
Shim HJ; Lee EJ; Kim JH; Kim SH; Kwon JW; Kim WB; Cha SW; Lee MG
Biopharm Drug Dispos; 2001 Apr; 22(3):109-17. PubMed ID: 11745913
[TBL] [Abstract][Full Text] [Related]
6. Subchronic toxicity and toxicokinetics of LZB, a new proton pump inhibitor, after 13-week repeated oral administration in dogs.
Mao Y; Zhang X; Li L; Yuan B; Lu G
Regul Toxicol Pharmacol; 2008 Feb; 50(1):75-86. PubMed ID: 18039554
[TBL] [Abstract][Full Text] [Related]
7. General 4-week toxicity study with EMS in the rat.
Pfister T; Eichinger-Chapelon A
Toxicol Lett; 2009 Nov; 190(3):271-85. PubMed ID: 19442710
[TBL] [Abstract][Full Text] [Related]
8. Toxicity and toxicokinetics of metformin in rats.
Quaile MP; Melich DH; Jordan HL; Nold JB; Chism JP; Polli JW; Smith GA; Rhodes MC
Toxicol Appl Pharmacol; 2010 Mar; 243(3):340-7. PubMed ID: 20004680
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers.
Bergman AJ; Stevens C; Zhou Y; Yi B; Laethem M; De Smet M; Snyder K; Hilliard D; Tanaka W; Zeng W; Tanen M; Wang AQ; Chen L; Winchell G; Davies MJ; Ramael S; Wagner JA; Herman GA
Clin Ther; 2006 Jan; 28(1):55-72. PubMed ID: 16490580
[TBL] [Abstract][Full Text] [Related]
10. Acute, subacute and chronic oral toxicity studies of the new serotonin (5-HT)3-receptor antagonist ramosetron in beagle dogs.
Tabata H; Matsuzawa T; Hanada T; Ishikawa A; Yamada M; Ozaki H; Izumisawa N; Barker MH; Cox RA; Buist DP
Arzneimittelforschung; 1995 Jul; 45(7):760-6. PubMed ID: 8573218
[TBL] [Abstract][Full Text] [Related]
11. Subchronic oral toxicity of ubiquinol in rats and dogs.
Kitano M; Watanabe D; Oda S; Kubo H; Kishida H; Fujii K; Kitahara M; Hosoe K
Int J Toxicol; 2008; 27(2):189-215. PubMed ID: 18404543
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of duloxetine hydrochloride enteric-coated tablets in healthy Chinese volunteers: a randomized, open-label, single- and multiple-dose study.
Zhao RK; Cheng G; Tang J; Song J; Peng WX
Clin Ther; 2009 May; 31(5):1022-36. PubMed ID: 19539103
[TBL] [Abstract][Full Text] [Related]
13. Subacute toxicity evaluation of a new camptothecin anticancer agent CKD-602 administered by intravenous injection to rats.
Kim JC; Shin DH; Kim SH; Kim JK; Park SC; Son WC; Lee HS; Suh JE; Kim CY; Ha CS; Chung MK
Regul Toxicol Pharmacol; 2004 Dec; 40(3):356-69. PubMed ID: 15546689
[TBL] [Abstract][Full Text] [Related]
14. Preclinical toxicity of a geldanamycin analog, 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (17-DMAG), in rats and dogs: potential clinical relevance.
Glaze ER; Lambert AL; Smith AC; Page JG; Johnson WD; McCormick DL; Brown AP; Levine BS; Covey JM; Egorin MJ; Eiseman JL; Holleran JL; Sausville EA; Tomaszewski JE
Cancer Chemother Pharmacol; 2005 Dec; 56(6):637-47. PubMed ID: 15986212
[TBL] [Abstract][Full Text] [Related]
15. [Pharmacokinetics of fudosteine in healthy volunteers].
Ding L; Yang J; Li RS; Zhou M; Shen JP; Zhang YD
Yao Xue Xue Bao; 2005 Oct; 40(10):945-9. PubMed ID: 16408815
[TBL] [Abstract][Full Text] [Related]
16. Sixty-day repeated dose toxicity of sinafloxacin in rats and dogs.
Lu GC; She JH; Jiang H; Li ZY; Yuan BJ
Food Chem Toxicol; 2008 Feb; 46(2):575-80. PubMed ID: 17942207
[TBL] [Abstract][Full Text] [Related]
17. A subchronic intravenous toxicity study of magnesium fructose-1,6-diphosphate in beagle dogs.
Wang M; Yao J; Chen JY; Bai WX; Mei SY; Pan WN; Pan YY; Yu FL
Basic Clin Pharmacol Toxicol; 2009 Feb; 104(2):93-100. PubMed ID: 19053993
[TBL] [Abstract][Full Text] [Related]
18. Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1,080 pg versus oral transmucosal fentanyl citrate 1,600 pg and dose proportionality of FEBT 270 to 1,300 microg: a single-dose, randomized, open-label, three-period study in healthy adult volunteers.
Darwish M; Tempero K; Kirby M; Thompson J
Clin Ther; 2006 May; 28(5):715-24. PubMed ID: 16861093
[TBL] [Abstract][Full Text] [Related]
19. Subchronic toxicity and toxicokinetics of MCC-555, a novel thiazolidinedione, after 270-day repeated oral administration in dogs.
Sun N; Lu G; Lin M; Fan G; Wu Y
Environ Toxicol Pharmacol; 2009 Mar; 27(2):237-46. PubMed ID: 21783946
[TBL] [Abstract][Full Text] [Related]
20. The safety of ethyl oleate is supported by a 91-day feeding study in rats.
Bookstaff RC; Stuard SB; Ward SR; Pesik PK; Henwood SM
Regul Toxicol Pharmacol; 2004 Apr; 39(2):202-13. PubMed ID: 15041149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
